(VIANEWS) – The Market ended the session with EUROAPI (EAPI.PA) rising 12.39% to €11.93 on Tuesday while CAC 40 dropped 1.22% to €7,406.08.
About EUROAPI
Euroapi S.A. develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the composition of drugs for human and veterinary use. It provides contract development manufacturing organization for different classes of tides that uses solid phase chemistry; particle engineering; microbial fermentation; small molecules synthesis; prostaglandins; steroids & hormones; and Opiates and controlled substances. The company was incorporated in 2021 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, EUROAPI has a trailing twelve months EPS of €-0.16.
Volatility
EUROAPI’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.29%, a positive 0.16%, and a positive 1.45%.
EUROAPI’s highest amplitude of average volatility was 0.89% (last week), 1.13% (last month), and 1.45% (last quarter).
Volume
Today’s last reported volume for EUROAPI is 898187 which is 374.74% above its average volume of 189192.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, EUROAPI’s stock is considered to be overbought (>=80).
More news about EUROAPI (EAPI.PA).
